Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Nephrogenic systemic fibrosis.php on line 2
Nephrogenic systemic fibrosis
LE WE PMID CA
Nephrogenic systemic fibrosis1931Nephrogene systemische Fibrose

Liver (MRT)

Nephrogenic systemic fibrosis

Scleredema

Sclerodermia

Scleromyxedema

Shulman s syndrome Eosinophilic fasciitis

Skin (Fibrosis)

2008  
1
Gadolinium and nephrogenic systemic fibrosis: the evidence of things not seen.
[18290354] Cleve Clin J Med 75(2): 112, 114, 117 (2008)
2008  
2
Nephrogenic systemic fibrosis and its association with gadolinium exposure during MRI.
[18290353] Cleve Clin J Med 75(2): 95-7, 103-4, 106 passim (2008)
2007  
3
Nephrogenic fibrosing dermopathy: report of two cases.
[17989891] Acta Derm Venereol 87(6): 521-4 (2007)
2006  
4
Nephrogenic fibrosing dermopathy: case report and review.
[16638421] Dermatol Online J 12(3): 7 (2006)
2009  
5
Current status of gadolinium toxicity in patients with kidney disease.
[19201920] Clin J Am Soc Nephrol 4(2): 461-9 (2009)
2007  
6
Nephrogenic systemic fibrosis, kidney disease, and gadolinium: is there a link?
[17699407] Clin J Am Soc Nephrol 2(2): 200-2 (2007)
2010  
7
Nephrogenic systemic fibrosis: a survey of nephrologists' perceptions and practices.
[20299369] Clin J Am Soc Nephrol 5(6): 964-71 (2010)
2004  
8
Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure.
[14736976] Nephrol Dial Transplant 19(2): 469-73 (2004)
2007  
9
Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders.
[17907160] Arthritis Rheum 56(10): 3173-5 (2007)
2008  
10
How should nephrologists approach gadolinium-based contrast imaging in patients with kidney disease?
[18385396] Clin J Am Soc Nephrol 3(3): 649-51 (2008)
2007  
11
New insights into nephrogenic systemic fibrosis.
[17855637] J Am Soc Nephrol 18(10): 2636-43 (2007)
2007  
12
Nephrogenic systemic fibrosis--the need for a multidisciplinary approach.
[17617650] Nephrol Dial Transplant 22(11): 3097-101 (2007)
2008  
13
MRI safety update 2008: part 1, MRI contrast agents and nephrogenic systemic fibrosis.
[18806155] AJR Am J Roentgenol 191(4): 1129-39 (2008)
2008  
14
Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
[18356456] AJR Am J Roentgenol 190(4): 1060-8 (2008)
2007  
15
Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned.
[17242272] AJR Am J Roentgenol 188(2): 586-92 (2007)
2009  
16
Nephrogenic systemic fibrosis and its impact on abdominal imaging.
[19959508] Radiographics 29(6): 1565-74 (2009)
2010  
17
Nephrogenic systemic fibrosis: risk factors suggested from Japanese published cases.
[20413447] Br J Radiol 83(991): 590-5 (2010)
2007  
18
Nephrogenic systemic fibrosis: risk factors and incidence estimation.
[17267695] Radiology 243(1): 148-57 (2007)
2007  
19
Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis.
[17213364] Radiology 242(3): 647-9 (2007)
2009  
20
Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.
[19789233] Radiology 253(3): 689-96 (2009)
2009  
21
Features of nephrogenic systemic fibrosis on radiology examinations.
[19542396] AJR Am J Roentgenol 193(1): 61-9 (2009)
2009  
22
Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis.
[18952698] Nephrol Dial Transplant 24(3): 856-63 (2009)
2007  
23
The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy--report of two cases and review of the literature.
[17124282] Nephrol Dial Transplant 22(2): 631-6 (2007)
2009  
24
Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases.
[19188312] Radiology 250(2): 371-7 (2009)
2009  
25
Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: case series of 36 patients.
[19709997] Radiology 253(1): 81-9 (2009)
2008  
26
Nephrogenic systemic fibrosis: a chemical perspective.
[18487530] Radiology 247(3): 608-12 (2008)
2008  
27
Gadolinium chelate-associated nephrogenic systemic fibrosis.
[18362996] Singapore Med J 49(3): 181-5 (2008)
2009  
28
Nephrogenic systemic fibrosis: mini-review.
[19488616] Clinics (Sao Paulo) 64(5): 482-4 (2009)
2010  
29
Nephrogenic systemic fibrosis: a concise review for cardiologists.
[20978560] Tex Heart Inst J 37(5): 508-15 (2010)
2008  
30
Gadolinium and nephrogenic systemic fibrosis: time to tighten practice.
[17943276] Pediatr Radiol 38(5): 489-96; quiz 602-3 (2008)
2010  
31
Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data.
[21179310] World J Radiol 2(11): 427-33 (2010)
2008  
32
2006  
33
Nephrogenic systemic fibrosis: A serious late adverse reaction to gadodiamide.
[17061066] Eur Radiol 16(12): 2619-21 (2006)
2009  
34
Nephrogenic systemic fibrosis in liver disease: a systematic review.
[19937937] J Magn Reson Imaging 30(6): 1313-22 (2009)
2006  
35
Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature.
[16461069] Semin Arthritis Rheum 35(4): 238-49 (2006)
2010  
36
Nephrogenic systemic fibrosis.
[21283650] F1000 Med Rep 2(-): 84 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Nephrogenic systemic fibrosis.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Nephrogenic systemic fibrosis.php on line 92